Armistice Capital’s NeuroSense Therapeutics NRSN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-1,584,000
| Closed | -$1.77M | – | 301 |
|
|
2024
Q2 | $1.77M | Buy |
+1,584,000
| New | +$1.77M | 0.02% | 147 |
|
|
2023
Q4 | – | Sell |
-662,000
| Closed | -$470K | – | 339 |
|
|
2023
Q3 | $470K | Sell |
662,000
-604,000
| -48% | -$429K | 0.01% | 166 |
|
|
2023
Q2 | $1.89M | Buy |
+1,266,000
| New | +$1.89M | 0.03% | 145 |
|